Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis: executive summary of recommendations from the American Dental Association Council on Scientific Affairs. [electronic resource]
Producer: 20120404Description: 1243-51 p. digitalISSN:- 1943-4723
- Antibodies, Monoclonal -- adverse effects
- Antibodies, Monoclonal, Humanized
- Biomarkers -- blood
- Bisphosphonate-Associated Osteonecrosis of the Jaw -- prevention & control
- Bone Density Conservation Agents -- adverse effects
- Collagen Type I -- blood
- Denosumab
- Dental Care for Chronically Ill
- Diphosphonates -- adverse effects
- Humans
- Oral Hygiene
- Oral Surgical Procedures
- Osteoporosis -- drug therapy
- Patient Care Planning
- Peptides -- blood
- RANK Ligand -- antagonists & inhibitors
- Risk Factors
No physical items for this record
Publication Type: Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review
There are no comments on this title.
Log in to your account to post a comment.